Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoichi Matsuda

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Molecular and Cellular Biochemistry|December 18, 2017
Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathwayAkira Wagatsuma, Yuzo Takayama, Takayuki Hoshino, et al.
Experimental Cell Research|June 25, 2014
Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activationYosuke Nagata, Kazuya Ohashi, Eiji Wada, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 10, 2006
Sphingomyelin levels in the plasma membrane correlate with the activation state of muscle satellite cellsYosuke Nagata, Hideshi Kobayashi, Masato Umeda, et al.
Journal of Biochemistry|October 1, 2010
Muscle injury-induced thymosin β4 acts as a chemoattractant for myoblastsYuka Tokura, Yuki Nakayama, So-Ichiro Fukada, et al.
Molecular and Cellular Biochemistry|July 9, 2011
Pharmacological inhibition of HSP90 activity negatively modulates myogenic differentiation and cell survival in C2C12 cellsAkira Wagatsuma, Masataka Shiozuka, Naoki Kotake, et al.
Journal of Biochemistry|November 14, 2009
Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disordersMasataka Shiozuka, Akira Wagatsuma, Tadafumi Kawamoto, et al.
Human Molecular Genetics|August 15, 2018
A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4Mitsuru Sasaki-Honda, Tatsuya Jonouchi, Meni Arai, et al.
The Journal of Cell Biology|September 11, 2002
Alpha1-syntrophin-deficient skeletal muscle exhibits hypertrophy and aberrant formation of neuromuscular junctions during regenerationYukio Hosaka, Toshifumi Yokota, Yuko Miyagoe-Suzuki, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Structure-Activity Relationship Study of Leucyl-3-<i>epi</i>-deoxynegamycin for Potent Premature Termination Codon ReadthroughAkihiro Taguchi, Keisuke Hamada, Masataka Shiozuka, et al.
The American Journal of Pathology|September 2, 2014
Dietary phosphorus overload aggravates the phenotype of the dystrophin-deficient mdx mouseEiji Wada, Mizuko Yoshida, Yoriko Kojima, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Molecular and Cellular Biochemistry|December 18, 2017
Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathwayAkira Wagatsuma, Yuzo Takayama, Takayuki Hoshino, et al.
Experimental Cell Research|June 25, 2014
Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activationYosuke Nagata, Kazuya Ohashi, Eiji Wada, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 10, 2006
Sphingomyelin levels in the plasma membrane correlate with the activation state of muscle satellite cellsYosuke Nagata, Hideshi Kobayashi, Masato Umeda, et al.
Journal of Biochemistry|October 1, 2010
Muscle injury-induced thymosin β4 acts as a chemoattractant for myoblastsYuka Tokura, Yuki Nakayama, So-Ichiro Fukada, et al.
Molecular and Cellular Biochemistry|July 9, 2011
Pharmacological inhibition of HSP90 activity negatively modulates myogenic differentiation and cell survival in C2C12 cellsAkira Wagatsuma, Masataka Shiozuka, Naoki Kotake, et al.
Journal of Biochemistry|November 14, 2009
Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disordersMasataka Shiozuka, Akira Wagatsuma, Tadafumi Kawamoto, et al.
Human Molecular Genetics|August 15, 2018
A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4Mitsuru Sasaki-Honda, Tatsuya Jonouchi, Meni Arai, et al.
The Journal of Cell Biology|September 11, 2002
Alpha1-syntrophin-deficient skeletal muscle exhibits hypertrophy and aberrant formation of neuromuscular junctions during regenerationYukio Hosaka, Toshifumi Yokota, Yuko Miyagoe-Suzuki, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Structure-Activity Relationship Study of Leucyl-3-<i>epi</i>-deoxynegamycin for Potent Premature Termination Codon ReadthroughAkihiro Taguchi, Keisuke Hamada, Masataka Shiozuka, et al.
The American Journal of Pathology|September 2, 2014
Dietary phosphorus overload aggravates the phenotype of the dystrophin-deficient mdx mouseEiji Wada, Mizuko Yoshida, Yoriko Kojima, et al.
Pageof 5